LNSR
LENSAR Inc.
Company Overview
| Mkt Cap | $128.40M | Price | $11.51 |
| Volume | 58.66K | Change | +0.09% |
| P/E Ratio | -4.1 | Open | $11.59 |
| Revenue | $53.5M | Prev Close | $11.50 |
| Net Income | $-31.4M | 52W Range | $7.13 - $17.31 |
| Div Yield | N/A | Target | $15.00 |
| Overall | 50 | Value | 40 |
| Quality | 57 | Technical | 54 |
No chart data available
About LENSAR Inc.
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LNSR | $11.51 | +0.1% | 58.66K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |